Clinical Trial

Mindfulness And Placebo for Pain (MAPP) Study

Study acronym: MAPP
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This study proposes a three-arm randomized-controlled trial (RCT) that evaluates the feasibility and acceptability of combining a mindfulness-based therapy (MBT) and open-label placebo (OLP) treatment for individuals with chronic pain. Individuals with chronic pain will be recruited to participate in an 8-week trial, with a subsequent 3-month post-treatment follow-up. Participants will be randomly assigned to one of the following three conditions: 1. Mindfulness-Based Stress Reduction (MBSR) 2. OLP treatment 3. combination of MBSR and OLP treatment
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-07-25
Trial Details
NCT Number NCT06720909
Lead Sponsor Arizona State University
Collaborators: National Center for Complementary and Integrative Health (NCCIH)
Conditions Chronic Pain
Enrollment 45 participants
Start Date 2025-01-27
Primary Completion 2027-03-01 (estimated)
Study Completion 2027-03-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-24